Rock River Capital Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Atrilityatrility.comNov 2025
Atrility makes the AtriAmp, an FDA-cleared device that connects temporary atrial pacing wires to a bedside patient monitor to provide continuous, real-time atrial electrograms for diagnosing post-operative cardiac arrhythmias.
HardwareHealthtechMedical DevicesMadison, US
Nicholas Von Bergen(Director)Sean McCormick(Executive Officer, Director)Peter Lukszys(Executive Officer, Director)
BoardMichael Partsch(Director)
Board seatChristopher Eckstrom· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.